Recently, vtRNA2-1 was proposed as a new type of ncRNA functioning as a tumor suppressor that inhibits Protein Kinase RNA-activated (PKR), and was consequently renamed as “nc886” [12,13,14,15]. This evidence concerns the gene EIF2AK2 and neoplasm.